Ultra-portable Ultrasound vs. Standard Ultrasound to Help Place a Peripheral Catheter in Patients at Risk of Difficult Puncture

The placement of an intravenous (IV) line is a common procedure when treating adult patients in critical care, in the emergency room or in the operating room. This simple and minimally invasive procedure can sometimes be made difficult depending on the patient's morphology or their clinical condition. The procedure then becomes time-consuming, anxiety-provoking, painful and its success is uncertain.

The placement of intravenous (IV) lines under ultrasound by nurses is a rapidly developing alternative in intensive care, emergencies and the operating room.

Study Overview

Detailed Description

The main objective is to test the hypothesis that intravenous puncture guided by an ultraportable ultrasound machine is faster than puncture guided by a conventional ultrasound machine.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhone-alpes
      • Lyon, Rhone-alpes, France, 69007
        • Saint Joseph Saint Luc Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Emmanuel VIVIER, MD
        • Sub-Investigator:
          • Raphaël STREIFF, MD
        • Sub-Investigator:
          • Guillaume MARCOTTE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient aged at least 18 years old
  2. Patient with an A-DIVA (Adult Difficult Intravenous Access) score > 1
  3. Supported by a nurse trained in all the techniques used in the protocol
  4. Patient having given free, informed and oral consent -

Exclusion Criteria:

  1. Patient who has already been included in the study
  2. Patient whose inclusion in the study would lead to a delay in treatment
  3. Adult patient protected by law
  4. Pregnant woman
  5. Patient not benefiting from French Social Security system -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard ultrasound
Comparator
Placement of IV line using standard ultrasound.
Experimental: Ultra-portable ultrasound
Placement of IV line using ultra-portable ultrasound.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intravenous (IV) line placement time
Time Frame: Day 0
Time in minutes between tourniquet placement and dressing application after placement.
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Placement of the IV line successfully obtained from the first puncture
Time Frame: 12 months (estimated)
Percentage of cases where the placement of the IV line was obtained from the first puncture
12 months (estimated)
Number of skin perforations
Time Frame: Day 0
Number of skin perforations required to establish the IV line
Day 0
Overall success rate after 3 punctures
Time Frame: Day 0
Overall success rate after 3 punctures
Day 0
Use an alternative solution (central catheter)
Time Frame: Day 0
Need to use an alternative solution (central catheter)
Day 0
Patient satisfaction with IV line placement
Time Frame: Day 0
Patient satisfaction with intravenous line placement (assessed by Likert scale)
Day 0
Nurse satisfaction with IV line placement
Time Frame: Day 0
Nurse satisfaction with intravenous line placement (assessed by Likert scale)
Day 0
Immediate complications related to intravenous access
Time Frame: Day 0
Number of immediate complications related to intravenous access, including arterial puncture and/or hematoma formation
Day 0
Delayed complications related to intravenous access
Time Frame: Day 7
Number of delayed complications related to intravenous access, including extravasation and/or the occurrence of infectious thrombophlebitis
Day 7
Date of IV line placement and removal
Time Frame: Day 7
Delays between IV line placement and removal
Day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

February 22, 2024

First Submitted That Met QC Criteria

February 28, 2024

First Posted (Estimated)

March 6, 2024

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

February 28, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ULTRACATHLON

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on IV Line Placement With Ultrasound

Clinical Trials on Standard ultrasound

3
Subscribe